Qt Imaging Holdings (QTI) Income from Continuing Operations (2021 - 2026)
Qt Imaging Holdings' (QTI) quarterly Income from Continuing Operations came in at 5656000.0 in Q1 2026, up 42.23% year-on-year from 3976583.08 in Q1 2025, and down 307.47% on a QoQ basis from 1388079.0 in Q4 2025.
Qt Imaging Holdings (QTI) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has 6 years of Income from Continuing Operations data on file, last reported at 5656000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 42.23% year-over-year to 5656000.0 in Q1 2026; TTM through Mar 2026 was 15603000.0, a 14.02% increase from a year earlier, with the FY2025 full-year figure at 21083000.0, down 134.65% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 5656000.0, down from 1388079.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for QTI reached as high as 369935.0 in Q1 2022 and fell as low as 9791000.0 in Q1 2025.
- Historically, Income from Continuing Operations has averaged 2760132.82 across 5 years, with a median of 1500691.0 in 2023.
- Across the five-year window, Income from Continuing Operations slumped 934.81% in 2022 and jumped 60.2% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 1372532.0 in 2022, then increased by 14.34% to 1175705.0 in 2023, then slumped by 196.68% to 3488042.0 in 2024, then soared by 60.2% to 1388079.0 in 2025, then slumped by 307.47% to 5656000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 5656000.0 in Q1 2026, 1388079.0 in Q4 2025, and 4557406.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Qt Imaging Holdings | 33.72 Mn | 26.82 Mn | 2.67 Mn | -5.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.66 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | -4.56 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -9.79 Mn |
| Dec 31, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -4.30 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | -1.43 Mn |
| Mar 31, 2023 | -1.99 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Sep 30, 2022 | -395,766.00 |
| Jun 30, 2022 | -636,074.00 |
| Mar 31, 2022 | -369,935.00 |
| Dec 31, 2021 | -867,753.00 |
| Sep 30, 2021 | -204,228.00 |
| Mar 31, 2021 | -35,749.00 |